170748 ⎘
Post-translational modifications [PTMs] in chemical analysis of biological material addition of addition of other proteins or peptides, e.g. SUMOylation, ubiquitination
METHODS AND COMPOSITIONS FOR TAUOPATHY DIAGNOSIS AND TREATMENT
#2Anti-Polyubiquitin Multispecific Antibodies
#3Methods and Compositions for Targeting Polyubiquitin
#4THIOL VARIANTS AND ANALYTICAL METHODS THEREOF
#5REGULATORS OF CELL DIVISION
#6METHODS AND COMPOSITIONS FOR TREATING ACUTE MYELOID LEUKEMIA
#7Screening method for effective target - E3 ligase combinations
#8METHOD FOR IDENTIFYING UBIQUITIN AND UBIQUITIN-LIKE ENZYME ACTIVITIES
#9DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS
#10Anti-polyubiquitin multispecific antibodies
#11SUMO INHIBITOR COMPOUNDS AND USES THEREOF
#12INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF
#13Anti-polyubiquitin antibodies and methods of use
#14METHOD FOR IDENTIFYING A CHEMICAL COMPOUND OR AGENT INDUCING UBIQUITINATION OF A PROTEIN OF INTEREST
#15Methods and compositions for targeting polyubiquitin
#16Compositions and methods for enrichment and detection of ubiquitin and ubiquitin conjugates
#17Anti-polyubiquitin multispecific antibodies
#18Anti-polyubiquitin antibodies and methods of use
#19Method of diagnosing arthritis or other joint degrading disease
#20Sumoylation of Serca2A and Cardiovascular Disease
#21Methods and compositions for targeting polyubiquitin
#22Method for identifying polyubiquitinated substrate
#23Probes and assays for measuring E3 ligase activity
#24Methods of identifying SENP1 inhibitors
#25Hybrid protein for the identification of neddylated substrates
#26HISTONE PROTEIN UBIQUITINATION AS A CANCER BIOMARKER
#27Methods of reducing viscosity of biological samples
#28SUMOylation assay and related reagents
#29Sumoylation of SERCA2a and cardiovascular disease
#30Methods and compositions for targeting polyubiquitin
#31Method of generating linkage-specific di-and polyprotein probes
#32METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS
#33Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood
#34Probes and assays for measuring E3 ligase activity
#35METHODS FOR IDENTIFYING PROTEINS AND COMPOUNDS THAT MODULATE THE ACTIVITY OF OTUB1
#36Methods and compositions for targeting polyubiquitin
#37Compositions and methods for inducing conformational changes in cereblon and other E3 ubiquitin ligases
#38MARKER FOR DEPRESSION, ASSAY METHOD, METHOD FOR DETERMINING DEPRESSION, SCREENING METHOD FOR ANTIDEPRESSANTS, AND KIT
#39PGC-1beta-protein-function regulator, mitochondria-function regulator, anti-obesity agent, and screening method therefor
#40Method and antibodies for the identification of ubiquitinated proteins and sites of ubiquitination
#41Diagnostic method based on large scale identification of post-translational modification of proteins
#42Anti-polyubiquitin antibodies and methods of use
#43Method for determining ubiquitin chain length
#44Methods of identifying SENP1 inhibitors
#45Ubiquitin chain analysis
#46Methods and compositions for inhibiting neddylation of proteins
#47Methods and kits for diagnosing Sjögren's syndrome
#48Analysis of ubiquitinated polypeptides
#49SUMO as a marker of cancer development and target for cancer therapy
#50Detection and quantification of modified proteins
#51Methods and compositions for targeting polyubiquitin
#52Anti-polyubiquitin antibodies and methods of use
#53ANALYSIS OF UBIQUITINATED POLYPEPTIDES
#54DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS
#55Methods and compositions for targeting polyubiquitin
#56Detection and quantification of modified proteins
#57Pharmacological profiling of drugs with cell-based assays